ebola

Hospital-acquired infections are a major public health concern the risk of getting an infection while in the hospital is roughly 1 in 20. They are also an especially substantial burden because they are often difficult to treat due to their antibiotic resistance (therefore being dubbed superbugs). Just a few of these bacteria include MRSA, VRE, and CRE, which the CDC refers to as nightmare bacteria.
In an opinion piece published in today s Wall Street Journal, Dr. Henry I. Miller, Robert Wesson Fellow in Scientific Philosophy and Public Policy at Stanford s Hoover Institution and former ACSH trustee, discusses the significant benefit that biopharming can provide for the development of medicines if only regulators can become more tolerant.
For anyone who has followed the AIDS epidemic from the beginning, Anthony Fauci is a very familiar name. Dr. Fauci, an accomplished immunologist, became the director of National Institute of Allergy
The latest health news: Our take on the Ebola outbreak, why your smartphone isn't as smart as it could be, and how Europe is overcoming the antibiotic resistance crisis
If you have noticed the absence of any mention of the ongoing ebola outbreak from us, there is a reason. Unlike many people who have been shooting their mouths off about the infection often contradicting each other we have not had the expertise to address this properly. This has now changed.